SCHEMBL5598455

SCHEMBL5598455

O=[C]OC=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL235127 0.64
SCHEMBL6260808 0.61
SCHEMBL3429776 0.61
SCHEMBL5695361 0.61
SCHEMBL514667 0.57
SCHEMBL11036541 0.57
SCHEMBL37344 0.57
SCHEMBL134185 0.57
SCHEMBL262302 0.57
SCHEMBL468478 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114867351-A 4' -halo-containing nucleotide and nucleoside therapeutic compositions and uses related thereto 埃默里大学 2022-08-05 CN claimed
CN-113557021-A Dihydropyrazolopyrazinone derivatives having MGAT2 inhibitory activity 盐野义制药株式会社 2021-10-26 CN disclosed
WO-2020022350-A1 ISOXAZOLIN-5-ONE DERIVATIVE, AND HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENT 北興化学工業株式会社 2020-01-30 WO disclosed
US-7226946-B2 Substituted phenol compounds useful for anesthesia and sedation THERAVANCE, INC. (US) 2007-06-05 US disclosed
US-20050032753-A1 Substituted phenol compounds useful for anesthesia and sedation THERAVANCE BIOPHARMA R&D IP, LLC 2005-02-10 US disclosed
US-6815555-B2 CONTAINING AN ESTER, ANHYDRIDE, PHOSPHONATE OR THIOESTER GROUP THERAVANCE, INC. 2004-11-09 US disclosed
EP-1430017-A2 SUBSTITUTED PHENOL COMPOUNDS USEFUL FOR ANESTHESIA AND SEDATION Theravance, Inc. (US) 2004-06-23 EP disclosed
US-20030119790-A1 Substituted phenol compounds useful for anesthesia and sedation THERAVANCE BIOPHARMA R&D IP, LLC 2003-06-26 US disclosed
WO-2003026632-A2 SUBSTITUTED PHENOL COMPOUNDS USEFUL FOR ANESTHESIA AND SEDATION THERAVANCE, INC. (US) 2003-04-03 WO disclosed
US-6369177-B1 TRANSITION METAL IMINE COMPLEX, ORGANOMETALLIC, AND ALUMOXANE COMPOUNDS MITSUI CHEMICALS INC (JP) 2002-04-09 US disclosed
EP-0626077-B1 IMAGE-RECORDING MATERIALS POLAROID CORP (US) 2001-11-21 EP disclosed
US-6313243-B1 FOR OBTAINING OLEFIN POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION MITSUI CHEMICALS INC (JP) 2001-11-06 US disclosed
EP-1004600-A1 CATALYST FOR OLEFIN POLYMERIZATION AND METHOD OF POLYMERIZING OLEFIN Mitsui Chemicals, Inc. (JP) 2000-05-31 EP disclosed
EP-1004599-A1 CATALYST FOR OLEFIN POLYMERIZATION AND METHOD OF POLYMERIZING OLEFIN Mitsui Chemicals, Inc. (JP) 2000-05-31 EP disclosed
US-4650868-A 7-deazapurine derivatives useful as antitumor agents TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-03-17 US disclosed
EP-0160910-A2 7-Deazapurine derivatives and their production Takeda Chemical Industries, Ltd. (JP) 1985-11-13 EP disclosed
EP-0000644-A2 Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1979-02-07 EP disclosed